Intech Biopharm Corporation (6461)
TWSE
Closed
Oct 2, 2026
Day's Range
24.0552 wk Range
22.79Overview - 6461 - Intech Biopharm Corporation
Key Statistics
Valuation
Enterprise Value
3.83B
P/E (Trailing)
‪-10.29‬
PEG Ratio
‪-0.06‬
Price / Sales (TTM)
‪54.64‬
Price / Book
‪2.96‬
EV / EBITDA
‪-10.24‬
Profitability
Gross Margin
‪-251.94%‬
Profit Margin
‪-103.17%‬
Operating Margin
‪-517.15%‬
Return on Assets
‪-11.56%‬
Return on Equity
‪-47.57%‬
Ownership
Shares Outstanding
110.32M
Float
58.52M
Held by Insiders
‪52.27%‬
Held by Institutions
‪5.04%‬
Price stats
Beta
‪0.10‬
50-Day Avg
‪25.53‬
200-Day Avg
‪28.72‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 6461 - Intech Biopharm Corporation
Peers - 6461 - Intech Biopharm Corporation
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
- 6461TWSEIntech Biopharm Corporation2.91BMarket Cap-9.40%52-week change-10.29P/E (Trailing)‪-103.17%‬Profit Margin
- 6696TWSELin BioScience, Inc.149.25BMarket Cap+89.39%52-week change-108.13P/E (Trailing)‪0.00%‬Profit Margin
- 6949TWSEPell Bio-Med Technology Co., Ltd.58.33BMarket Cap-798.88%52-week change-6.16P/E (Trailing)‪-13.97%‬Profit Margin
- 6919TWSECaliway Biopharmaceuticals Co., Ltd.42.55BMarket Cap—52-week change-155.08P/E (Trailing)‪70.55%‬Profit Margin
- 6586TWSECho Pharma Inc.24.82BMarket Cap+68.19%52-week change-85.29P/E (Trailing)‪74.49%‬Profit Margin
- 4743TWSEOneness Biotech Co., Ltd.22.58BMarket Cap-37.79%52-week change362.69P/E (Trailing)‪39.54%‬Profit Margin
- 4728TWSESunmax Biotechnology Co., Ltd.21.48BMarket Cap+0.38%52-week change26.53P/E (Trailing)‪36.97%‬Profit Margin
Profile Summary - 6461 - Intech Biopharm Corporation
About
Intech Biopharm Corporation is a specialty pharmaceutical company established in 2010 and headquartered in Taipei, Taiwan. The company focuses on the development, manufacturing, and commercialization of inhalation-based medicines, primarily targeting respiratory diseases such as asthma and chronic obstructive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
